As of June 2026, 1 paid clinical trial is recruiting for Hepatology in Arlington, Virginia. Hepatology research evaluates antifibrotic drugs, FXR and GLP-1 agonists for fatty liver disease, antiviral therapies, and liver cancer treatments across cirrhosis, NAFLD/NASH, and hepatocellular carcinoma. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Arlington has approximately 33 recruiting research studies across a wide range of therapeutic areas. Virginia hosts the University of Virginia Health System, VCU Health, and Inova Health System, running clinical trials across oncology, cardiology, and neuroscience.
Researchers run research studies in Arlington, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Cancer Specialists, PC | Breast Cancer, Breast Neoplasms, Colonic Diseases | 4 |
| Sana Research, LLC | Alzheimers Disease | 2 |
| Virginia Cancer Specialists | Colorectal Neoplasms | 2 |
| Care Access - Arlington- Site Number : 8401134 | Dermatitis Atopic | 1 |
| Care Access Alexandria | Hidradenitis Suppurativa | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Conquest Research | Heart Failure, Obesity | 1 |
| Conquest Research ( Site 0045) | Hyperlipidemia | 1 |
| Conquest Research, LLC | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| HealthQare Associates | Diabetes, End Stage Renal Disease | 1 |
| ISA Associates | Uterine Cervical Neoplasms | 1 |
| Investigational Site 10 | Subcutaneous Fat | 1 |
| Investigative Site US248 | Hidradenitis Suppurativa | 1 |
| Local Institution - 007-814-D | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 017-814-A | Advanced NSCLC, Metastatic Lung Cancer | 1 |
| Local Institution - 1241 | Psychosis Associated With Alzheimer's Disease | 1 |
| Panoramic Health - Virginia Nephrology Group | Kidney Disease | 1 |
| RAND | Birth, Maternal Health, Pregnancy | 1 |
| SkinDC | Moderate to Severe Glabellar Lines | 1 |
| SkinDC /ID# 254962 | Acne Scars | 1 |
| SkinDC /ID# 258163 | Mid Face Volume Deficit | 1 |
| Virginia Nephrology | Focal Segmental Glomerulosclerosis | 1 |
| Virginia Nephrology Group | Chronic Kidney Disease | 1 |
| Washington Cntr Weight Mgmt | Obesity | 1 |
| Washington Radiology | Mammography | 1 |
Recruiting trials in Arlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Virginia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Virginia research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Arlington from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 33 recruiting clinical trials in Arlington, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Arlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Arlington include Colorectal Neoplasms (3), Obesity (3), Alzheimers Disease (2), Hidradenitis Suppurativa (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Arlington include Virginia Cancer Specialists, PC, Sana Research, LLC, Virginia Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Arlington are Cancer & tumors (7), Diabetes & metabolic (4), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.